A phase II randomized study of cisplatin (CDDP), raltitrexed (TOM), levofolinic acid (LFA), and 5-fluorouracil (5-FU), or CDDP, methotrexate (MTX), LFA and 5-FU in locally advanced (LAD) or metastatic (M) head and neck cancer (HNC)

2001 ◽  
Vol 37 ◽  
pp. S105-S106
Author(s):  
F. Caponigro ◽  
P. De Rosa ◽  
G. Rosati ◽  
A. Avallone ◽  
L. De Lucia ◽  
...  
2011 ◽  
Vol 38 (1) ◽  
pp. 108-113 ◽  
Author(s):  
Imjai Chitapanarux ◽  
Vicharn Lorvidhaya ◽  
Ekasit Tharavichitkul ◽  
Somvilai Mayurasakorn ◽  
Pichit Sittitrai ◽  
...  

2018 ◽  
Vol 49 (1) ◽  
pp. 37-41 ◽  
Author(s):  
Takashi Matsuzuka ◽  
Naomi Kiyota ◽  
Junki Mizusawa ◽  
Tetsuo Akimoto ◽  
Masato Fujii ◽  
...  

Cancer ◽  
1989 ◽  
Vol 63 (3) ◽  
pp. 423-427 ◽  
Author(s):  
Kathleen A. Havlin ◽  
John G. Kuhn ◽  
J. William Myers ◽  
Robert F. Ozols ◽  
Douglas E. Mattox ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document